Columbia, IL, United States of America

Tiffani Eisenhauer

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Tiffani Eisenhauer in Pharmaceutical Compositions

Introduction

Tiffani Eisenhauer is an accomplished inventor based in Columbia, IL (US), known for her contributions to the field of pharmaceutical sciences. With a remarkable portfolio of three patents, Tiffani has been instrumental in developing methods that enhance the stability and effectiveness of solid dosage forms of pharmaceutical compositions.

Latest Patents

Tiffani's latest patents focus on innovative methods for producing stabilized solid dosage pharmaceutical compositions containing morphinans. These methods detail the preparation of protected granules that incorporate morphinans, leading to the creation of high-quality solid dosage forms. The patents provide significant advancements in the pharmaceutical industry by ensuring the stability and efficacy of these compositions.

Career Highlights

Tiffani currently works at Mallinckrodt, Inc., a company renowned for its commitment to improving patient health through innovative medicines. Her role within the organization has allowed her to leverage her expertise in pharmaceutical formulation to contribute to significant advancements in drug development.

Collaborations

Throughout her career, Tiffani has collaborated with esteemed colleagues, including Jae Han Park and Anish Dhanarajan. These collaborations highlight the importance of teamwork and shared knowledge in driving innovation forward, particularly in the complex field of pharmaceutical research.

Conclusion

Tiffani Eisenhauer's work exemplifies the vital role inventors play in shaping the future of healthcare through innovations in pharmaceutical compositions. Her patents not only reflect her dedication to science but also pave the way for safer, more effective therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…